Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, April 25, 2023.
More diabetes and robotic surgery innovations are in the news today. The FDA approved Medtronic’s newest iteration of its MiniMed insulin pump. Sean Whooley gives a detailed look at the newest device and what sets it apart from other versions.
Philips has been dealing with a series of recalls related to its Respironics line of devices. This week, the company posted Q1 earnings and announced recall litigation provisions. Hosts Danielle Kirsh and Whooley discuss what that means for the company and what investors have to say about it.
Smith+Nephew is a major player in the robotic-assisted surgery market with its orthopedic offerings. It recently launched a digital tensioning device to supplement its robotic system. Whooley describes the new device and how it fits into Smith+Nephew’s current offerings.
Major innovations are taking place in the neurology space. Axonics, which is working on sacral neuromodulation, recently acquired technology to speed up the placement of implantable leads during peripheral nerve evaluation. Fast Five hosts Kirsh and Whooley talk about neuromodulation and what executives at the company think about the acquisition.
There could be a major acquisition on the horizon. Whooley details reports of Boston Scientific eyeing an acquisition of Shockwave Medical. Shockwave Medical has a market valuation of $9.6 billion and has a stake in the cardiology market. Hear more details and what analysts have to say about the potential acquisition in this week’s episode of the MassDevice Fast Five.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.